Dr. Sulaiman Al Habib Medical Services Group Company

4013.SRSAUHealthcare● Active

$218.70

+$2.50(+1.16%)

Market Cap$76.5B

P/E Ratio—

52W High$281.2

52W Low$211.5

Avg Volume184K

Open$217.00

Beta0.05

Cash on Hand Financials Revenue

Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

4013.SR · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$2.28B▼ -21.1% vs prior year

FY · as of Dec 31, 2025 · Reported in SAR

Cash & Cash Equiv. (CCE)

$2.28B

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-21.1%

vs prior fiscal year

Latest Quarter

$2.42B

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$2.28BCash on Hand

Total Debt$9.30BTotal Debt

Net Cash / Net Debt−$7.02BNet Debt Position

Cash vs Debt Ratio

Cash 20%Dr. Sulaiman Al Habib Medical Services Group Company cash as % of market cap: 2.98%% · MCap $77BDebt 80%

Dr. Sulaiman Al Habib Medical Services Group Company carries a net debt position of $7.02B. Total debt ($9.30B) exceeds cash on hand ($2.28B). Dr. Sulaiman Al Habib Medical Services Group Company cash vs debt ratio: 20% cash / 80% debt.

Net Cash = Cash & ST Investments − Total Debt$2.28B − $9.30B = −$7.02B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

4013.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

4013.SR cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$2.28B-21.1%

Dec 31, 2024FY$2.89B+10.3%

Dec 31, 2023FY$2.62B-4.6%

Dec 31, 2022FY$2.75B+3.9%

Dec 31, 2021FY$2.64B+13.0%

4013.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

4013.SR vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Dr. Sulaiman Al Habib Medical Services Group CompanyYOU

4013.SR

$2.28B$77B3.0%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) cash on hand as of December 31, 2025 is $2.28B, comprising $2.28B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Dr. Sulaiman Al Habib Medical Services Group Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Dr. Sulaiman Al Habib Medical Services Group Company cash reserves or cash position.

Dr. Sulaiman Al Habib Medical Services Group Company annual cash on hand history shows decreased -21.1% in 2025: decreased -21.1% in 2025. Dr. Sulaiman Al Habib Medical Services Group Company cash reserves in 2025 reflect the company's capital allocation strategy.

Dr. Sulaiman Al Habib Medical Services Group Company carries total debt of $9.30B against cash of $2.28B, resulting in a net debt position of -$7.02B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

4013.SR cash on hand · 5 questions

As of December 31, 2025, Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) has $2.28B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2.28B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2.42B. Data sourced from the annual 10-K filing via FMP.

4013.SR cash on hand4013.SR cash reserves4013.SR cash 2025how much cash does 4013.SR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Dr. Sulaiman Al Habib Medical Services Group Company · Dr. Sulaiman Al Habib Medical Services Group Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025